QT Vascular enrols first patients for Chocolate Touch study

Singapore

CATALIST-LISTED healthcare company QT Vascular has announced that it has enrolled the first 11 patients in its First-In-Human (FIH) study of its novel Chocolate Touch PTCA (Coronary Drug Coated Chocolate) in the Dominican Republic.

In a filing to the Singapore Exchange on Tuesday, the group said it is working closely with local and United States physicians on the study, which will evaluate the clinical utility of the Chocola…